Prof. Ernest Fraenkel, co-founder and a member of the board of directors
Prof. Fraenkel is a tenured associate professor at MIT Biological Engineering departments. He has extensive expertise in developing computational and experimental approaches to search for new therapeutic strategies for diseases.
Prof. Clary Clish
Clary Clish is the director of the Metabolomics Platform at the Broad Institute of MIT and Harvard. He is an expert in metabolomic profiling.
Prof. Matthew Vander Heiden
Prof. Vander Heiden is an associate professor of Biology at MIT. He is an expert in understanding cancer cell metabolism.